Research changes the world.
Increase the sensitivity of liquid biopsies, neurons in the human brain able to predict what we’re going to say before we say it and much more
How Daniel Faden, MD, and his team are working on developing and applying blood based cancer diagnostic tools.
It took contributions from almost 100 people to translate promising lab findings into a first-in-human treatment for glioblastoma.
Mass General researchers and clinicians share science-backed findings about the importance of sleep health.
Cancer Grand Challenges: Record £100m awarded to five teams taking on cancer’s toughest challenges, including Andrew Chan, MD, MPH, from Massachusetts General Hospital.
Increase the sensitivity of liquid biopsies, neurons in the human brain able to predict what we’re going to say before we say it and much more
Vanessa Merker,PhD, has spent her 14-year career at Mass General working to improve care for patients with schwannomatosis and NF2.
Genevieve Boland, MD, PhD, a physician-investigator in the Cancer Center at Mass General, is researching skin cancer and related diseases.
What started as an investigation into a rare skin disease led one researcher to new insights about kidney formation and function.
This year’s Claflin award winners share what the recognition means to them and their careers.